Browsing by Author "Jeffrey Hanna"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    PublicationMetadata only
    Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
    (2011-11-28) Sai Kit Lam; Donald Burke; Maria Rosario Capeding; Chee Keong Chong; Laurent Coudeville; Jeremy Farrar; Duane Gubler; Sri Rezeki Hadinegoro; Jeffrey Hanna; Jean Lang; Han Lim Lee; Yee Sin Leo; Chan Quang Luong; Richard Mahoney; John Mcbride; Jorge Mendez-Galvan; Lee Ching Ng; Suchitra Nimmannitya; Eng Eong Ooi; Donald Shepard; Jaco Smit; Rémy Teyssou; Laurent Thomas; Joseph Torresi; Pedro Vasconcelos; Dewa Nyoman Wirawan; Sutee Yoksan; University of Malaya; University of Pittsburgh Graduate School of Public Health; Gokila; Kementerian Kesihatan Malaysia; Sanofi Pasteur; University of Oxford; National University of Singapore; Ministry of Health, Republic of Indonesia; Tropical Population Health Unit; Institute for Medical Research Kuala Lumpur; Tan Tock Seng Hospital; Pasteur Institute in Ho Chi Minh City; International Vaccine Institute, Seoul; James Cook University, Australia; Hospital Infantil de Mexico Federico Gomez; National Environmental Authority; Thailand Ministry of Public Health; Brandeis University; Emergency Network at the University Hospital of Fort-de-France; Austin Center for Infection Research; Instituto Evandro Chagas; School of Public; Mahidol University
    Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now. © 2011 Elsevier Ltd.
  • Thumbnail Image
    PublicationOpen Access
    Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
    (2011-11-28) Sai Kit Lam; Donald Burke; Maria Rosario Capeding; Chee Keong Chong; Laurent Coudeville; Jeremy Farrar; Duane Gubler; Sri Rezeki Hadinegoro; Jeffrey Hanna; Jean Lang; Han Lim Lee; Yee Sin Leo; Chan Quang Luong; Richard Mahoney; John Mcbride; Jorge Mendez Galvan; Lee Ching Ng; Suchitra Nimmannitya; Eng Eong Ooi; Donald Shepard; Jaco Smit; Rémy Teyssou; Laurent Thomas; Joseph Torresit; Pedro Vasconcelos; Dewa Nyoman Wirawan; Sutee Yoksan; Mahidol University. Institute of Molecular Biosciences
    Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now.